Humacyte, Inc. (HUMA)

NASDAQ: HUMA · IEX Real-Time Price · USD
4.71
0.02 (0.43%)
At close: May 20, 2022 4:00 PM
4.91
0.20 (4.25%)
After-hours:May 20, 2022 5:13 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Revenue
1.261.496.19
Revenue Growth (YoY)
-15.29%-75.90%-
Gross Profit
1.261.496.19
Selling, General & Admin
21.1312.0116.28
Research & Development
61.3454.0875.6
Operating Expenses
82.4766.0991.88
Operating Income
-81.21-64.6-85.69
Interest Expense / Income
4.352.22.3
Other Expense / Income
-59.08-0.28-2.57
Pretax Income
-26.48-66.52-85.42
Net Income
-26.48-66.52-85.42
Net Income Common
-26.48-66.52-85.42
Shares Outstanding (Basic)
40620
Shares Outstanding (Diluted)
40620
Shares Change
593.25%-71.34%-
EPS (Basic)
-0.66-11.54-4.25
EPS (Diluted)
-0.66-11.54-4.25
Free Cash Flow Per Share
-2.04-9.68-3.97
Gross Margin
100.00%100.00%100.00%
Operating Margin
-6429.77%-4332.66%-1385.02%
Profit Margin
-2096.36%-4461.70%-1380.67%
Free Cash Flow Margin
-6445.76%-3744.87%-1291.61%
EBITDA
-13.85-55.89-76.31
EBITDA Margin
-1096.28%-3748.49%-1233.44%
EBIT
-22.13-64.32-83.12
EBIT Margin
-1752.10%-4314.02%-1343.53%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).